Potential Therapeutic Drugs for Parkinson’s Disease Based on Data Mining and Bioinformatics Analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Therapeutic Drugs for Parkinson’s Disease Based on Data Mining and Bioinformatics Analysis
Authors
Keywords
-
Journal
Parkinsons Disease
Volume 2018, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2018-10-03
DOI
10.1155/2018/3464578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel indanone derivatives as MAO B/H 3 R dual-targeting ligands for treatment of Parkinson’s disease
- (2018) Anna Affini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Vitamin B12 and Parkinson's Disease: What is the Relationship?
- (2018) Francisco Cardoso MOVEMENT DISORDERS
- Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test
- (2018) Cettina Allone et al. Psychogeriatrics
- Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy
- (2018) Jon Kirk et al. SUPPORTIVE CARE IN CANCER
- Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test
- (2018) Cettina Allone et al. Psychogeriatrics
- Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease
- (2017) Muhammet Ay et al. JOURNAL OF NEUROCHEMISTRY
- A Systematic Review to Identify Unacceptable Intake Levels of Vitamin B6 among Patients Taking Levodopa
- (2017) Yoko SATO et al. Food Hygiene and Safety Science
- Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry
- (2017) Stefano Delli Pizzi et al. MEDICINE
- Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson’s disease: A meta-analysis
- (2017) Yi Xie et al. NEUROSCIENCE LETTERS
- DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
- (2017) Kelsy C Cotto et al. NUCLEIC ACIDS RESEARCH
- Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
- (2017) Hojin Kang et al. Oncotarget
- A Systematic Review to Identify Unacceptable Intake Levels of Vitamin B6 among Patients Taking Levodopa
- (2017) Yoko SATO et al. Food Hygiene and Safety Science
- Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson’s disease
- (2016) S Lehmann et al. Cell Death & Disease
- Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease
- (2015) Marianne Amalric CURRENT OPINION IN PHARMACOLOGY
- Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria
- (2015) Hyunjin Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson’s Disease
- (2015) K. M. Denny Joseph et al. NEUROCHEMICAL RESEARCH
- PubChemRDF: towards the semantic annotation of PubChem compound and substance databases
- (2015) Gang Fu et al. Journal of Cheminformatics
- Associations between B Vitamins and Parkinson’s Disease
- (2015) Liang Shen Nutrients
- Drug discovery through stem cell-based organoid models
- (2014) Adrian Ranga et al. ADVANCED DRUG DELIVERY REVIEWS
- Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments
- (2014) Anna Astashkina et al. ADVANCED DRUG DELIVERY REVIEWS
- Enteric GFAP expression and phosphorylation in Parkinson's disease
- (2014) Thomas Clairembault et al. JOURNAL OF NEUROCHEMISTRY
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Methamphetamine-induced neurotoxicity: the road to Parkinson’s disease
- (2014) Bessy Thrash et al. Pharmacological Reports
- Oral Drug Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians
- (2013) ANNALS OF INTERNAL MEDICINE
- Systems biology in drug discovery and development
- (2013) Ellen L. Berg DRUG DISCOVERY TODAY
- Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study
- (2012) Mark L Wahlqvist et al. BMC Medicine
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Changes in Chemosensitivity and Mechanosensitivity in Aging and Parkinson’s Disease
- (2011) Li Pyn Leow et al. DYSPHAGIA
- D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease
- (2011) Evgenia Gelfin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Gene prioritization and clustering by multi-view text mining
- (2010) Shi Yu et al. BMC BIOINFORMATICS
- Polyamine pathway contributes to the pathogenesis of Parkinson disease
- (2010) N. M. Lewandowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of functionally related genes using data mining and data integration: a breast cancer case study
- (2009) Ettore Mosca et al. BMC BIOINFORMATICS
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More